{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-086639","form_type":"8-K","ticker":"APM","cik":"0001734005","company_name":"Aptorum Group Ltd","filed_at":"2026-08-07T20:00:46+00:00","discovered_at":"2026-08-07T20:02:00.474378+00:00","generated_at":"2026-08-07T20:02:04.324339+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Niki BioSolutions regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq deficiency letter on March 5, 2026 for bid price below $1.00 for 30 consecutive business days.","On August 4, 2026, Nasdaq confirmed compliance as closing bid price was $1.00+ for 10 consecutive days (July 21-Aug 3, 2026).","Listing matter now closed; company avoids delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-086639","json":"https://secwatch.observer/filing/0001213900-26-086639.json","markdown":"https://secwatch.observer/filing/0001213900-26-086639.md","text":"https://secwatch.observer/filing/0001213900-26-086639.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1734005/000121390026086639/0001213900-26-086639-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1734005/000121390026086639/ea0300774-8k_nikibio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-07T20:02:04.324339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}